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Abstract: Hyperglycaemia is prevalent in critical 
care, and tight control can reduce mortality by 29 - 
45%. Targeted glucose control can be achieved by 
frequent fitting and prediction of a modelled insulin 
sensitivity index, SI. This parameter varies 
significantly in the critically ill due to condition 
evolution and drug therapies. A 3-D stochastic model 
of hourly SI variability is constructed using 
retrospective data from 18 long term critical care 
patients. The model can be used to produce the blood 
glucose level probability distribution one hour 
following a known insulin and/or nutrition 
intervention. Thus, it enables accurate prediction for 
glycemic control based on confidence intervals. 
 
Introduction 
 
Hyperglycemia and severe insulin resistance are 
prevalent in the critically ill, even given no history of 
diabetes [1-3]. Tight glucose control has been shown to 
reduce Intensive Care Unit (ICU) patient mortality by 
up to 45% [1-3]. Therefore, tight regulation glycemic 
control algorithms in the ICU would reduce mortality 
and the burden on time and medical resources. 
Previous clinical glycemic control studies [4] 
focused on critical care patients, whose glucose-insulin 
dynamics are highly variable due to the stress from their 
condition and the impact of drug therapies. Chase et al. 
[4] developed a control algorithm that has been 
clinically verified in the ICU to predicatively reduce 
hyperglycaemic levels, while accounting for inter-
patient variability and evolving physiological condition. 
The overall approach is a targeted adaptive control 
scheme that identifies patient dynamics, particularly 
with respect to insulin sensitivity. 
Following Chase et al. [4], better understanding and 
modelling of patient variability in the ICU can lead to 
better glycemic management. In particular, a common 
risk in intensive insulin therapies in the ICU, is 
hypoglycemic events [1, 5]. Understanding and 
modelling the variability in patient condition, or more 
specifically, the patients’ variable dynamic response to 
insulin, will thus assist clinical control intervention 
decision making, and minimise the associated risk. 
Therefore, the ultimate goal of this study is to 
produce blood glucose confidence bands for control 
intervention decisions based on stochastic models of 
clinically observed parameter variations. These bands 
allow targeted control with user specified confidence on 
the outcome. The result will be added certainty and 
safety in glycemic control. 
 
Glucose-Insulin System Model 
 
This study uses a patient-specific, two-compartment 
glucose-insulin system model from Chase et al. [4] and 
Hann et al. [6]. This physiologically verified model, 
which captures the fundamental dynamic responses to 
elevated glycemic levels and insulin, accounts for time-
varying insulin sensitivity and endogenous glucose 
removal, along with two different saturation kinetics. 
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where G and I denote the glucose above an equilibrium 
level, GE, and the plasma insulin from an exogenous 
insulin input respectively. Insulin utilization over time is 
Q, where k is the effective insulin decay rate. Patient 
endogenous glucose removal and insulin sensitivity are 
pG and SI. Insulin distribution volume is VI and n 
represents plasma insulin decay. External nutrition and 
insulin input are P(t) and uex(t). Michaelis-Menten 
saturation in plasma insulin disappearance and insulin-
stimulated glucose removal are defined by αI and αG. 
Insulin sensitivity, SI, is the critical parameter that 
drives the dynamics of the system. It represents the 
tissue insulin sensitivity, and its variation shows the 
evolution of patient condition and drug therapy. 
Identifying SI and its changes over time is thus critical 
to providing safe and effective tight glycemic control in 
the highly variable critical care population. 
 
Integral-Based Parameter Identification 
 
Using generic values for αG, αI, n, k and VI limits the 
model unknowns to pG and SI, as shown in Equations 
(1)-(3). An integration-based parameter identification 
method presented in Hann et al. [6] is used for accurate 
identification of patient specific parameters, pG and SI. 
The functions for pG and SI can be arbitrarily defined. 
The integral-based method presents a convex least 
squares problem that demands little computational 
effort. In contrast, the commonly used non-linear 
recursive least squares routine is non-convex and 
starting point dependent [7]. Details of the fitting 
routine are outlined in Hann et al. [6]. 
 
Stochastic Modelling 
 
Patient parameters, pG and SI are fitted to long term 
retrospective clinical data from 18 patients in the 
Department of Intensive Care Medicine, Christchurch 
Hospital. These patients are a random selection from a 
201-patients data audit [8]. Each patient record spans at 
least one day with data every three-hours or less. This 
cohort broadly represents the cross section of patients 
seen in the ICU, regarding medical condition, age, sex, 
APACHE II scores and mortality. Diabetic patients are 
somewhat over-represented as they receive greater 
attention in blood glucose levels. 
Zero order piecewise linear functions are used to 
define pG and SI, with a discontinuity every two hours 
for pG and every hour for SI. Greater variability is given 
to SI because studies have shown that SI is much more 
variable than pG [6]. Table 1 shows the values used for 
the generic parameters based on various studies [9-11]. 
 
Table 1. Generic parameter values [9-11] 
 
Parameter Unit Value 
αG L/mU 1/65 
αI L/mU 0.0017 
n min-1 0.16 
k min-1 0.0198 
VI L 3.15 
 
The fitted long term pG and SI data reveals that the 
variability of both parameters is dependent on its 
present value. The distribution of fitted SI is shown by 
the dots in Figure 1. The probability distribution of 
potential SI, shown by the probability bands, clearly 
varies with its value across the horizontal axis.  
 
 
 
Figure 1. Fitted SI and probability intervals 
 
Thus, the variations in SI can be treated as a Markov 
process. A Markov process has the property that the 
conditional probability distribution of future states of 
the process, given the present state, depends only upon 
the current state. Therefore, using the Markov property 
of the stochastic behaviour of SI, the conditional 
probability distribution of SI n+1 taking on a value y can 
be calculated by knowing SI n = x: 
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Considering the fitted SI in a 2-D space, as shown in 
Figure 1, the joint probability function across the x-y (SI 
n - SI n+1) plane is defined by the fitted values shown by 
the dots whose coordinates are xi and yi, 
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Effectively, the 2-D joint probability function is the 
normalised summation of normal probability 
distribution functions ),;( 2
ixi
xx σφ  centred at individual 
data points. 
To illustrate a 3-D map in the mind, consider this 
numerical operation as a sand building exercise. If the 
first quadrant of the x-y (SI n - SI n+1) plane, as shown in 
Figure 1, is where the sand box is confined in, and that a 
pile of sand of a cubic unit is dropped onto every dot in 
Figure 1, then the resulted sand sculpture is the simple 
representation of the joint probability P(x, y) on the x-y 
(SI n - SI n+1) plane. In Equations (5)-(7), the variance σ  
at each data point is a function of the local data density 
in a centred and orthonormalised space of x and y. 
Putting Equations (6) and (7) into Equation (5) 
normalises each ),;( 2
ixi
xx σφ  and ),;( 2
iyi
yy σφ  in the 
positive domain. This, in the sand building exercise 
example, effectively puts boundaries along x = 0 and y = 
0, confining sand to stay in the first quadrant, and 
therefore forces physiological validity in SI values. 
In Equation (4), the denominator in the right hand 
side can be calculated by integrating Equation (5) with 
respect to y. Hence, Equation (5) can be calculated: 
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Thus, knowing SI n = x at hour n, the probability of  
SI n+1 = y at hour n+1 can be calculated using Equations 
(8) and (9). The probability intervals shown in Figure 1 
are also calculated from integrating Equation (8). 
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Plotting Equation (8) across the x-y (SI n - SI n+1) plane, 
the 3-D stochastic model is shown in Figure 2. 
 
 
 
Figure 2. Three-dimensional SI stochastic model 
 
The same numerical operations described in 
Equations (4)-(9) also apply to pG, producing similar 
results. However the probability density across the x-y 
plane is highly concentrated along the line y = x. This 
result reinforces the idea that pG is effectively constant, 
even though patient specific [6]. Hence, variability of pG 
is neglected in this study. 
The stochastic parameter model can be integrated 
into the glucose-insulin system model of Equations (1)-
(3). This step allows the blood glucose level probability 
distribution one hour following a known insulin and/or 
nutrition intervention to be defined. The stochastic 
model therefore enables more knowledgeable 
predictions with defined probability distributions for the 
outcomes of glycemic control inputs. 
 
Validation on Clinical Control Trials 
 
The stochastic model developed from the 18-patients 
cohort in Hann et al. [6] is evaluated on 8 previous 
clinical control trials in the ICU [12] that are 
independent from the cohort used to develop the 
stochastic model. The trials performed consist of hourly 
cycles of the following steps [12]: 
 
1. Measure blood glucose levels. 
2. Fit pG and SI to the measured blood glucose.  
3. Determine new control intervention to achieve 
a blood glucose target level. 
4. Implement control intervention. 
 
To asses the stochastic model, these 8 trials are 
numerically re-enacted with control interventions as 
given in the trial and step 3 of the trial cycle modified 
to: 
 
3a. Generate potential SI probability intervals from 
the time-average identified SI of the fitted time 
interval using the stochastic model. 
3b. Calculate blood glucose confidence intervals 
with respect to the SI probability intervals using 
the numerical model in Equations (1)-(3). 
 
This test allows validation of the model in a clinical 
control scenario. 
 
Clinical Trial Review Results ad Discussion 
 
Blood glucose probability intervals were produced at 
each control intervention in the 8 clinical trials and 
compared to measured blood glucose levels one hour 
later. The results are shown in Table 2. Detailed result 
from Trial 4 is shown Figure 4. 
 
Table 2. Retrospective probabilistic assessment on 
clinical control trials 
 
Clinical 
control 
patients 
Number of 
interventions 
made 
Measurement 
error within 
inter-quartile 
probability 
interval 
Measurement 
error within 
0.90 
probability 
interval 
1 9 6 (67%) 9 (100%) 
2 9 5 (56%) 7 (78%) 
3 9 5 (56%) 8 (89%) 
4 9 5 (56%) 7 (78%) 
5 9 9 (100%) 9 (100%) 
6 9 9 (100%) 9 (100%) 
7 9 8 (89%) 9 (100%) 
8 23 16 (70%) 23 (100%) 
total 86 63 (73%) 81 (94%) 
 
 
 
Figure 4. Simulated clinical control trial on Patient 4 
 
The top panel of Figure 4 displays blood glucose, 
where the crosses are the actual clinical measurements 
with 7% measurement error, the solid line is the fitted 
blood glucose profile, and the circles are the most likely 
probabilistic blood glucose predictions following 
control interventions. The 0.90 and inter-quartile 
probability ranges are shown by the bars. The bottom 
panel shows the fitted SI and its probabilistic bounds 
produced from the stochastic model. 
Patient 4’s blood glucose briefly dropped below 4 
mmol/L during the trial, which was not accounted for in 
the probabilistic forecast. Having the identified Patient 4 
SI profile, different control interventions were explored 
using the SI stochastic model to assist decision making. 
A comparison between the clinical trial and simulated 
new control intervention results is shown in Figure 5. 
0 100 200 300 400 500 6002
4
6
8
10
Bl
o
o
d 
G
lu
co
se
 
(m
m
o
l/L
)
0 100 200 300 400 500 6000
0.2
0.4
0.6
0.8
1 x 10
-3
Time (min)
S I
 
(m
U/
L/
m
in
)
hourly average of fitted SI
 
0.90 probability interval Inter-quartile interval 
most probable SI
 
fitted SI
 
measurement probabilistic prediction 
fitted blood 
glucose 
  
 
Figure 5. Clinical trial vs. simulated new control results 
on Patient 4 
 
The simulated control aimed to maintain the 
glycemic levels close to but above 4 mmol/L. More 
aggressive interventions were issued in the first half of 
the simulated trial, achieving more tightly controlled 
glycemic levels. The brief blood glucose excursion 
below 4 mmol/L was still unavoidable because the SI 
variation exceeded the 0.90 confidence limit of the 
stochastic model. A more vigorous remedy action was 
taken at 360 minutes in the simulated trial to obtain a 
0.90 confidence in blood glucose above 4 mmol/L in an 
hour. Overall, the SI stochastic model can deliver tighter 
and safer glycemic management and improve control 
intervention selection. 
Across the 8 patients, the SI stochastic model 
successfully captures the identified SI variation trend, 
accounting for 94% of measurements over time within 
the 0.90 confidence band, and 73% with a 0.50 
confidence. Hence, the model may be slightly 
conservative, which is safe in control. 
When SI increases, the blood glucose level 
probability interval tightens. The wide range of 
uncertainties in blood glucose levels associated with 
low SI reflects the risk of insulin resistant patients under 
intensive insulin therapy encountering hypoglycaemia 
[5]. This situation was specifically seen in Patient 4, 
whose identified SI profile is in the lower physiological 
range. 
 
Conclusions 
 
The stochastic model presented defines the 
distribution of blood glucose levels one hour following 
a known insulin and/or nutrition intervention. It thus 
enables more knowledgeable and accurate prediction for 
glycemic control. The stochastic model acts as a tool to 
assist clinical intervention decisions, maximising the 
probability of achieving desired glycemic regulation 
while maintaining patient safety. The impact of control 
inputs on probabilistic blood glucose results can be 
assessed, giving confidence in the effectiveness of the 
control protocol against evolving patient dynamics. 
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